![Dario Campana](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dario Campana is the founder of Cogent Biosciences, Inc. (founded in 2014), Nkarta, Inc. (founded in 2005), and Medisix Therapeutics Pte Ltd. (founded in 2016).
He has a doctorate degree from the University of Milan and the University of Turin.
| Società | Posizione | Fine |
|---|---|---|
| NKARTA, INC. | Fondatore | - |
Medisix Therapeutics Pte Ltd.
 Medisix Therapeutics Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops T-cell therapies for T-cell malignancies, tumors and autoimmune diseases | Fondatore | - |
| COGENT BIOSCIENCES, INC. | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 5 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Turin
 University of Turin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Medisix Therapeutics Pte Ltd.
Medisix Therapeutics Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops T-cell therapies for T-cell malignancies, tumors and autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
